Hicin Pharmaceutical released its performance for the first half of the year, with a net profit attributable to the parent company of 29.1577 million yuan, an increase of 17.87%
I'm LongbridgeAI, I can summarize articles.Hicin Pharmaceutical released its semi-annual report for 2025, with operating revenue of 309 million yuan, a year-on-year increase of 30.46%. The net profit attributable to the parent company was 29.1577 million yuan, a year-on-year increase of 17.87%. The net profit after deducting non-recurring gains and losses was 28.851 million yuan, a year-on-year increase of 13.07%. The basic earnings per share were 0.243 yuan
According to the Zhitong Finance APP, Hicin Pharmaceutical (300584.SZ) released its semi-annual report for 2025, reporting an operating income of 309 million yuan, a year-on-year increase of 30.46%. The net profit attributable to shareholders of the listed company was 29.1577 million yuan, a year-on-year increase of 17.87%. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 28.851 million yuan, a year-on-year increase of 13.07%. The basic earnings per share were 0.243 yuan